vs
Side-by-side financial comparison of Park Hotels & Resorts Inc. (PK) and Insulet Corporation (PODD). Click either name above to swap in a different company.
Insulet Corporation is the larger business by last-quarter revenue ($783.7M vs $629.0M, roughly 1.2× Park Hotels & Resorts Inc.). Insulet Corporation runs the higher net margin — 13.0% vs -32.6%, a 45.6% gap on every dollar of revenue. On growth, Insulet Corporation posted the faster year-over-year revenue change (31.2% vs 0.6%). Insulet Corporation produced more free cash flow last quarter ($48.2M vs $-3.0M). Over the past eight quarters, Insulet Corporation's revenue compounded faster (33.2% CAGR vs -0.8%).
Park Hotels & Resorts is an American real estate investment trust (REIT) focused on hotel properties, based in Tysons, Virginia. It was formed in 2017 as a spin-off from Hilton Worldwide.
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
PK vs PODD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $629.0M | $783.7M |
| Net Profit | $-205.0M | $101.6M |
| Gross Margin | — | 72.6% |
| Operating Margin | -26.1% | 18.7% |
| Net Margin | -32.6% | 13.0% |
| Revenue YoY | 0.6% | 31.2% |
| Net Profit YoY | -410.6% | 0.9% |
| EPS (diluted) | $-1.04 | $1.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $629.0M | $783.7M | ||
| Q3 25 | $610.0M | $706.3M | ||
| Q2 25 | $672.0M | $649.1M | ||
| Q1 25 | $630.0M | $569.0M | ||
| Q4 24 | $625.0M | $597.5M | ||
| Q3 24 | $649.0M | $543.9M | ||
| Q2 24 | $686.0M | $488.5M | ||
| Q1 24 | $639.0M | $441.7M |
| Q4 25 | $-205.0M | $101.6M | ||
| Q3 25 | $-16.0M | $87.6M | ||
| Q2 25 | $-5.0M | $22.5M | ||
| Q1 25 | $-57.0M | $35.4M | ||
| Q4 24 | $66.0M | $100.7M | ||
| Q3 24 | $54.0M | $77.5M | ||
| Q2 24 | $64.0M | $188.6M | ||
| Q1 24 | $28.0M | $51.5M |
| Q4 25 | — | 72.6% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 69.7% | ||
| Q1 25 | — | 71.9% | ||
| Q4 24 | — | 72.1% | ||
| Q3 24 | — | 69.3% | ||
| Q2 24 | — | 67.7% | ||
| Q1 24 | — | 69.5% |
| Q4 25 | -26.1% | 18.7% | ||
| Q3 25 | 9.7% | 16.7% | ||
| Q2 25 | 9.7% | 18.7% | ||
| Q1 25 | 1.1% | 15.6% | ||
| Q4 24 | 13.3% | 18.3% | ||
| Q3 24 | 14.6% | 16.2% | ||
| Q2 24 | 17.6% | 11.2% | ||
| Q1 24 | 14.4% | 12.9% |
| Q4 25 | -32.6% | 13.0% | ||
| Q3 25 | -2.6% | 12.4% | ||
| Q2 25 | -0.7% | 3.5% | ||
| Q1 25 | -9.0% | 6.2% | ||
| Q4 24 | 10.6% | 16.9% | ||
| Q3 24 | 8.3% | 14.2% | ||
| Q2 24 | 9.3% | 38.6% | ||
| Q1 24 | 4.4% | 11.7% |
| Q4 25 | $-1.04 | $1.42 | ||
| Q3 25 | $-0.08 | $1.24 | ||
| Q2 25 | $-0.02 | $0.32 | ||
| Q1 25 | $-0.29 | $0.50 | ||
| Q4 24 | $0.32 | $1.38 | ||
| Q3 24 | $0.26 | $1.08 | ||
| Q2 24 | $0.30 | $2.59 | ||
| Q1 24 | $0.13 | $0.73 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $232.0M | — |
| Total DebtLower is stronger | $3.9B | $930.8M |
| Stockholders' EquityBook value | $3.1B | $1.5B |
| Total Assets | $7.7B | $3.2B |
| Debt / EquityLower = less leverage | 1.23× | 0.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $232.0M | — | ||
| Q3 25 | $278.0M | — | ||
| Q2 25 | $319.0M | — | ||
| Q1 25 | $233.0M | — | ||
| Q4 24 | $402.0M | — | ||
| Q3 24 | $480.0M | — | ||
| Q2 24 | $449.0M | — | ||
| Q1 24 | $378.0M | — |
| Q4 25 | $3.9B | $930.8M | ||
| Q3 25 | $3.9B | $934.9M | ||
| Q2 25 | $3.9B | $939.0M | ||
| Q1 25 | $3.9B | $1.6B | ||
| Q4 24 | $3.9B | $1.3B | ||
| Q3 24 | $3.9B | $1.4B | ||
| Q2 24 | $3.9B | $1.4B | ||
| Q1 24 | $3.8B | $1.4B |
| Q4 25 | $3.1B | $1.5B | ||
| Q3 25 | $3.4B | $1.4B | ||
| Q2 25 | $3.4B | $1.5B | ||
| Q1 25 | $3.5B | $1.3B | ||
| Q4 24 | $3.6B | $1.2B | ||
| Q3 24 | $3.8B | $1.1B | ||
| Q2 24 | $3.8B | $998.4M | ||
| Q1 24 | $3.8B | $790.7M |
| Q4 25 | $7.7B | $3.2B | ||
| Q3 25 | $8.8B | $3.0B | ||
| Q2 25 | $8.9B | $3.5B | ||
| Q1 25 | $8.9B | $3.5B | ||
| Q4 24 | $9.2B | $3.1B | ||
| Q3 24 | $9.2B | $3.0B | ||
| Q2 24 | $9.2B | $2.9B | ||
| Q1 24 | $9.1B | $2.6B |
| Q4 25 | 1.23× | 0.61× | ||
| Q3 25 | 1.14× | 0.68× | ||
| Q2 25 | 1.12× | 0.64× | ||
| Q1 25 | 1.11× | 1.21× | ||
| Q4 24 | 1.06× | 1.07× | ||
| Q3 24 | 1.03× | 1.21× | ||
| Q2 24 | 1.03× | 1.36× | ||
| Q1 24 | 1.00× | 1.72× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $105.0M | $183.3M |
| Free Cash FlowOCF − Capex | $-3.0M | $48.2M |
| FCF MarginFCF / Revenue | -0.5% | 6.2% |
| Capex IntensityCapex / Revenue | 17.2% | 17.2% |
| Cash ConversionOCF / Net Profit | — | 1.80× |
| TTM Free Cash FlowTrailing 4 quarters | $102.0M | $377.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $105.0M | $183.3M | ||
| Q3 25 | $99.0M | $125.7M | ||
| Q2 25 | $108.0M | $196.5M | ||
| Q1 25 | $86.0M | $63.8M | ||
| Q4 24 | $80.0M | $147.7M | ||
| Q3 24 | $140.0M | $98.5M | ||
| Q2 24 | $117.0M | $96.5M | ||
| Q1 24 | $92.0M | $87.6M |
| Q4 25 | $-3.0M | $48.2M | ||
| Q3 25 | $31.0M | $100.1M | ||
| Q2 25 | $65.0M | $177.9M | ||
| Q1 25 | $9.0M | $51.5M | ||
| Q4 24 | $17.0M | $94.1M | ||
| Q3 24 | $97.0M | $71.8M | ||
| Q2 24 | $66.0M | $74.0M | ||
| Q1 24 | $22.0M | $65.5M |
| Q4 25 | -0.5% | 6.2% | ||
| Q3 25 | 5.1% | 14.2% | ||
| Q2 25 | 9.7% | 27.4% | ||
| Q1 25 | 1.4% | 9.1% | ||
| Q4 24 | 2.7% | 15.7% | ||
| Q3 24 | 14.9% | 13.2% | ||
| Q2 24 | 9.6% | 15.1% | ||
| Q1 24 | 3.4% | 14.8% |
| Q4 25 | 17.2% | 17.2% | ||
| Q3 25 | 11.1% | 3.6% | ||
| Q2 25 | 6.4% | 2.9% | ||
| Q1 25 | 12.2% | 2.2% | ||
| Q4 24 | 10.1% | 9.0% | ||
| Q3 24 | 6.6% | 4.9% | ||
| Q2 24 | 7.4% | 4.6% | ||
| Q1 24 | 11.0% | 5.0% |
| Q4 25 | — | 1.80× | ||
| Q3 25 | — | 1.43× | ||
| Q2 25 | — | 8.73× | ||
| Q1 25 | — | 1.80× | ||
| Q4 24 | 1.21× | 1.47× | ||
| Q3 24 | 2.59× | 1.27× | ||
| Q2 24 | 1.83× | 0.51× | ||
| Q1 24 | 3.29× | 1.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PK
| Occupancy | $371.0M | 59% |
| Food And Beverage | $173.0M | 28% |
| Ancillary Hotel | $61.0M | 10% |
| Hotel Other | $24.0M | 4% |
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
